|
Protocol ID |
Official Title |
PI Name |
Lead CRC |
Disease Site |
Phase |
| CC-16047 ClinicalTrials.gov NCT02834052 | A phase I/II trial of pembrolizumab (MK-3475) and poly-ICLC in patients with metastatic mismatch repair-proficient (MRP) colon cancer | A. Nayak | Ashlyn Stevenson | Phase 1: All solid tumors, following at least one therapy Phase 2: Mismatch Repair Proficient “MRP” (includes microsatellite stable [MSS] and MSI-low) colon cancer that has progressed following at least two lines of therapy | I/II |
| NLG-2105 ClinicalTrials.gov: NCT02502708 | Phase 1 Trials of Indoximod in Combination with Temozolomide-based Therapy for Children with Progressive Primary Brain Tumors | T. Johnson | Robin Dobbins & Kimberly Gray | Pediatric Brain Tumor | I |
